HIV TREATMENT
2020
Pharmaceutical companies, SRAs, WHO Prequalification Programme (PQ) and NRAs commit to:
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Action 16
Assess acceptability and palatability of formulations for low-resource settings at early stages of the formulations development.
Committed by:
Pharmaceutical companies
Sub-Actions & Milestones
Sub-action 16.1
Assess acceptability and palatability of formulations for low-resource settings at early stages of the formulations development.
Pharmaceutical Companies
-
-
Milestone 16.1.1
-
-
-
-
Document (s)
-
-
-
-
Updates
Notes
Responsible